A Randomized, Crossover Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D® 12-Hour Extended Release Tablet (Loratadine 5mg/Pseudoephedrine Sulfate 120 mg, Manufacturer-SAG) to a Single Oral Dose of Claritin-D® 12-Hour Extended Release Tablet (Loratadine 5 mg/Pseudoephedrine Sulfate 120 mg, Manufacturer-Heist) Under Fed Conditions in Healthy Adult Subjects

To evaluate the bioequivalence of one extended release combination (loratadine 5 mg/pseudoephedrine sulfate 120 mg) tablet manufactured for Bayer HealthCare LLC by SAG Manufacturing, S.L.U. Madrid, Spain (test treatment) to the extended release combination (loratadine 5 mg/pseudoephedrine sulfate 120 mg) tablet manufactured for Bayer SA-NV by Schering- Plough Labo NV Heist (reference treatment) which is currently marketed in Europe.

开始日期2018-04-24

申办/合作机构

Bayer AG

NCT03517930 / Completed临床1期

To evaluate the bioequivalence of one extended release combination (loratadine 5 mg/pseudoephedrine sulfate 120 mg) tablet manufactured for Bayer HealthCare LLC by SAG Manufacturing, S.L.U. Madrid, Spain (test treatment) to the extended release combination (loratadine 5 mg/pseudoephedrine sulfate 120 mg) tablet manufactured for Bayer SA-NV by Schering-Plough Labo NV Heist (reference treatment) which is currently marketed in Europe.

开始日期2018-04-17

申办/合作机构

Bayer AG

NCT03443843 / Completed临床4期

A Double-Blind Placebo-Controlled Crossover Study to Evaluate Objective Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure in an Environmental Exposure Unit

The purpose of the study is to evaluate changes in nasal airflow caused by loratadine 5 mg/pseudoephedrine sulfate 120 mg (Claritin D) tablet and fluticasone propionate 50 mcg per spray nasal spray (Flonase) in subjects suffering from nasal congestion and other allergy symptoms.

开始日期2018-02-21

申办/合作机构

Bayer AG

100 项与 ADRA1 x β1-adrenergic receptor x ADRA2 x β3-adrenergic receptor x β2-adrenergic receptor x H1 receptor 相关的临床结果

登录后查看更多信息

100 项与 ADRA1 x β1-adrenergic receptor x ADRA2 x β3-adrenergic receptor x β2-adrenergic receptor x H1 receptor 相关的转化医学

登录后查看更多信息

0 项与 ADRA1 x β1-adrenergic receptor x ADRA2 x β3-adrenergic receptor x β2-adrenergic receptor x H1 receptor 相关的专利（医药）

登录后查看更多信息